We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $121M
1-Year Est. Return 56.89%
This Fund
S&P 500
This Quarter Est. Return
-7.49%
1 Year Est. Return
+56.89%
3 Year Est. Return
+244.35%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$211M
AUM Growth
-$127M
Cap. Flow
-$101M
Cap. Flow %
-47.95%
Top 10 Hldgs %
84.11%
Holding
64
New
9
Increased
4
Reduced
8
Closed
19

Top Buys

Rank Stock Value
1
TRDA icon
Entrada Therapeutics
TRDA
+$1.86M
2
REPL icon
Replimune Group
REPL
+$1.41M
3
CCXI
ChemoCentryx, Inc.
CCXI
+$1.01M
4
TSVT
2seventy bio
TSVT
+$683K
5
AFMD
Affimed
AFMD
+$353K

Top Sells

Rank Stock Value
1
NFH
New Frontier Health Corporation Ordinary Shares
NFH
+$95.7M
2
NFH.WS
New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
+$4.27M
3
TVTX icon
Travere Therapeutics
TVTX
+$1.5M
4
ASND icon
Ascendis Pharma A/S
ASND
+$977K
5
BLUE
bluebird bio
BLUE
+$783K

Sector Composition

Rank Sector Weight
1 Healthcare 98.98%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYMR icon
51
Kymera Therapeutics
KYMR
$8.96B
– –
-4,960
Closed -$315K
LEGN icon
52
Legend Biotech
LEGN
$4B
– –
-9,340
Closed -$435K
PRLD icon
53
Prelude Therapeutics
PRLD
$387M
– –
-20,350
Closed -$253K
SRZN icon
54
Surrozen
SRZN
$295M
– –
-4,338
Closed -$419K
TCRX icon
55
TScan Therapeutics
TCRX
$50.6M
– –
-48,600
Closed -$219K
TNGX icon
56
Tango Therapeutics
TNGX
$4.39B
– –
-25,500
Closed -$279K
TVTX icon
57
Travere Therapeutics
TVTX
$5.76B
– –
-48,500
Closed -$1.5M
ATYR
58
aTyr Pharma
ATYR
$50.8M
– –
-23,500
Closed -$176K
VINC
59
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
– –
-553
Closed -$113K
MRTX
60
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-1,810
Closed -$266K
DICE
61
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-19,700
Closed -$499K
AMYT
62
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
– –
-19,150
Closed -$207K
NFH
63
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
– –
-8,350,000
Closed -$95.7M
NFH.WS
64
DELISTED
New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
– –
-1,580,000
Closed -$4.27M
1 2
3

Similar funds

MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
CCM
Candelo Capital Management New York $121M AUM 113.39% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
MW
Merited Wealth North Bay Village, Florida $121M AUM

Nan Fung Group Holdings's Q1 2022 Portfolio in Review

As of Q1 2022, Nan Fung Group Holdings held 64 positions worth $211M, down 38% from $338M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Nan Fung Group Holdings withdrew a net $101M in Q1 2022, closing 19 positions and reducing 8 holdings. Its most notable exit was New Frontier Health Corporation Ordinary Shares, an estimated $95.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 70% a quarter earlier, followed by Financials.

Against the trend, Nan Fung Group Holdings opened a new position in Entrada Therapeutics worth $1.63M.

  • Nan Fung Group Holdings's largest Q1 2022 buy was Entrada Therapeutics: 173,582 shares worth $1.63M.
  • Nan Fung Group Holdings added most to Kodiak Sciences in Q1 2022, an estimated $241K increase.
  • Nan Fung Group Holdings's biggest Q1 2022 reduction was Ascendis Pharma A/S, cutting an estimated $977K.
  • Nan Fung Group Holdings fully exited New Frontier Health Corporation Ordinary Shares in Q1 2022, selling an estimated $95.7M.
  • Nan Fung Group Holdings's ten largest holdings make up 84% of its $211M portfolio in Q1 2022.
  • Nan Fung Group Holdings opened 9 new positions and closed 19 in Q1 2022.
  • Nan Fung Group Holdings's portfolio value fell 38% quarter-over-quarter to $211M.

Based on Nan Fung Group Holdings's 13F filing for Q1 2022, filed 13 May 2022.